Chargement en cours...
Brolucizumab: evidence to date in the treatment of neovascular age-related macular degeneration
Age-related macular degeneration (AMD) is a global health concern and the leading cause of vision loss in the developed world. Intravitreal anti-vascular endothelial growth factor (VEGF) therapy has revolutionized the treatment of neovascular AMD, but there are still challenges with delivery of care...
Enregistré dans:
| Publié dans: | Clin Ophthalmol |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Dove
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6661993/ https://ncbi.nlm.nih.gov/pubmed/31413539 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OPTH.S184706 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|